buformin has been researched along with Alloxan Diabetes in 10 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The dextran-induced anaphylactoid reaction in the rat is susceptible to changes in carbohydrate metabolism." | 1.26 | Effect of oral antidiabetics on the anaphylactoid reaction. ( Koltai, M; Wellinger, K, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shroff, JR | 2 |
| Elpern, B | 1 |
| Kobrin, S | 2 |
| Cervoni, P | 2 |
| Bandurco, V | 1 |
| Desai, R | 1 |
| CREUTZFELDT, W | 1 |
| SOELING, HD | 1 |
| MOENCH, A | 1 |
| RAUH, E | 1 |
| BOL, M | 1 |
| HILDMANN, W | 1 |
| LIPPMANN, HG | 1 |
| LOOK, D | 1 |
| WAHL, P | 1 |
| Wellinger, K | 1 |
| Koltai, M | 1 |
| Hotta, N | 2 |
| Komori, T | 2 |
| Kobayashi, M | 1 |
| Sakakibara, F | 2 |
| Koh, N | 2 |
| Sakamoto, N | 1 |
| Mori, K | 1 |
| Nakamura, J | 1 |
| Hamada, Y | 1 |
| Hara, T | 1 |
| Nakashima, E | 1 |
| Naruse, K | 1 |
| Takeuchi, N | 1 |
| Tutwiler, GF | 1 |
| Bridi, G | 1 |
| Tragl, KH | 1 |
10 other studies available for buformin and Alloxan Diabetes
| Article | Year |
|---|---|
Chemistry and hypoglycemic activity of N-[[(Dialkylamino)alkoxy]phenyl]benzamidines.
Topics: Adrenalectomy; Amidines; Animals; Benzamidines; Chemical Phenomena; Chemistry; Diabetes Mellitus, Ex | 1982 |
Chemistry and hypoglycemic activity of benzimidoylpyrazoles.
Topics: Adrenalectomy; Animals; Benzimidazoles; Blood Glucose; Chemical Phenomena; Chemistry; Diabetes Melli | 1981 |
[The effect of Nl, n-butylbiguanide (W37) and Nl, beta-phenylethylbiguanide (W32) on alloxan and phlorrhizin diabetes and intestinal glucose absorption in rats].
Topics: Alloxan; Animals; Buformin; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Intestinal Absorpt | 1962 |
[ACTIVITIES OF GLUCOSE-6-PHOSPHATASE AND HEXOKINASE UNDER THE EFFECT OF N1,N-BUTYLBIGUANIDE].
Topics: Adenosine Triphosphatases; Animals; Buformin; Diabetes Mellitus, Experimental; Glucose-6-Phosphatase | 1963 |
[THE EFFECT OF N1-N-BUTYLBIGUANIDE ON OXYGEN AND GLUCOSE CONSUMPTION BY THE AORTA OF ALLOXAN DIABETIC RATS].
Topics: Alloxan; Animals; Aorta; Buformin; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Glucose | 1964 |
Effect of oral antidiabetics on the anaphylactoid reaction.
Topics: Anaphylaxis; Animals; Blood Glucose; Buformin; Dextrans; Diabetes Mellitus, Experimental; Female; Hy | 1981 |
The inhibitory action of buformin, a biguanide on gluconeogenesis from alanine and its transport system in rat livers.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Alanine; Animals; Biological Transport, Active; Buformin; Cell | 1993 |
Increased alanine uptake and lipid synthesis from alanine in isolated hepatocytes of Wistar-Kyoto fatty rats: an inhibitory effect of biguanides.
Topics: Aging; Alanine; Animals; Body Weight; Buformin; Cells, Cultured; Diabetes Mellitus, Experimental; Di | 1997 |
Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
Topics: Animals; Biguanides; Biological Transport, Active; Blood Glucose; Buformin; Diabetes Mellitus, Exper | 1978 |
[On the influence of oral antidiabetics on protein biosynthesis in vitro (author's transl)].
Topics: Animals; Buformin; Centrifugation, Density Gradient; Diabetes Mellitus, Experimental; Hypoglycemic A | 1976 |